510(k) Report

510(k) · Cleared

Cleared

Sedrite Plus Erythrocyte Sedimentation Rate

K991876510(k) TraditionalCleared Jun 17, 199915-day reviewClass II21 CFR 864.8625

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

R&D Systems, Inc. · JPK Mixture, Hematology Quality Control

Cleared on Jun 17, 1999 as substantially equivalent to K972172 (R&D Systems, Inc., 1997) after a 15-day review. Its family tree reaches back 2 generations to 1995.

Decided
Jun 17, 1999
Review
15 days
Class
Class II
Product code
JPK
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K940430 (1995). No later device cites it as a predicate yet.

  1. Root · 2 generations backK940430 SedratrolMedical Specialties Intl., Inc. · 1995
  2. 1 generation backK972172 Esr Control-M Hematology Erythrocyte SedimentationR&D Systems, Inc. · 1997
  3. This deviceK991876 Sedrite Plus Erythrocyte Sedimentation RateR&D Systems, Inc. · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K940430SedratrolMedical Specialties Intl., Inc.1995—
−1K972172Esr Control-M Hematology Erythrocyte SedimentationR&D Systems, Inc.1997—
0 (this device)K991876Sedrite Plus Erythrocyte Sedimentation RateR&D Systems, Inc.1999—
FIG. 1 — Lineage of K991876, 1995–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JPK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972172Esr Control-M Hematology Erythrocyte Sedimentation
Summary page 1
…mentation Rate Control currently being sold for in vitro diagnostic use. SEDRite™ is a trademark of R&D Systems, Inc. The FDA document number for the predicate device is K972172. Device description: SEDRIite™ Plus is an in vitro diagnostic reagent composed of mammalian erythrocytes suspended in a plasma-…
R&D Systems, Inc.1997—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 2 companies; a new generation was cleared every 2.5 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All JPK devices

JPK Mixture, Hematology Quality Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JPK

4in 2016

2007: 52009: 52010: 42011: 12012: 22013: 12014: 22016: 4
2007high 5 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JPK

296in 2016

2007: 44 days median2009: 187 days median2010: 267 days median2016: 296 days median
2007high 296 (2016) · low 44 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JPK

1in 2022

2007: 12010: 22011: 32012: 12020: 12021: 22022: 1
2007high 3 (2011) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JPK

2in 2023

2007: 142008: 12010: 52011: 562012: 22014: 12019: 12020: 12021: 12023: 2
2007high 56 (2011) · low 0 (2009)2025

MAUDE reports naming product code JPK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007544114
20080—01
2009518700
2010426725
20111—356
20122—12
20131—00
20142—01
20150—00
2016429600
20170—00
20180—00
20190—01
20200—11
20210—21
20220—10
20230—02
20240—00
20250—00
20260—0—

What is it indicated for?

It is an established laboratory procedure to use stable controls to monitor the performance of diagnostic tests. SEDRite™ Plus is a bi-level control for use in monitoring erythrocyte sedimentation rate (ESR) values obtained from manual and automated ESR methods.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K991876: Sedrite Plus Erythrocyte Sedimentation Rate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K991876

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026